Articles From: Regency Centers Reports First Quarter Results to Regional Banks to Benefit From Loan Growth and Improving Credit Quality


2013/5/7
Regency Centers Corporation (“Regency” or the “Company”) announced today financial and operating results for the quarter ended March 31, 2013.
Sign-up for Regency Centers Reports First Quarter Results investment picks
2013/1/30
Regency Centers Corporation (“Regency” or the “Company”) announced today financial and operating results for the quarter ended December 31, 2012.
Sign-up for Regency Centers Reports Fourth Quarter Results investment picks
2013/5/29
Regency Centers Corporation announced today that it is scheduled to make a presentation at the National Association of Real Estate Investment Trust’s REITWeek 2013 Investor Forum® on Wednesday, June 5 th at 8:45 am CT .
Sign-up for Regency Centers to Audio Webcast Presentation at NAREIT’s Investor Forum investment picks
2013/5/8
Regency Centers Corporation (NYSE:REG) , a national owner, operator and developer of grocery-anchored and community shopping centers, has begun construction on the first phase of Shops on Main, a 147,851-square-foot community shopping center anchored by Gordmans, Ross Dress for Less, HomeGoods and DSW Designer Shoe Warehouse.
Sign-up for Regency Centers to Begin 148,000 SF Ground-Up Retail Development in Schererville, Ind. investment picks
2013/3/27
Regency Centers (NYSE:REG) , a national owner, operator and developer of grocery-anchored and community shopping centers, increased its annual energy savings by 75 percent, achieved LEED® certification for three projects and tripled the amount of construction and demolition material recycled in 2012.
Sign-up for Regency Centers’ 2012 greengenuity® Metrics Show Improvements in Sustainability investment picks
2013/4/24
Regency Energy Partners LP ( NYSE: RGP ), (“Regency” or the “Partnership”), announced today a cash distribution of 46 cents per outstanding common unit for the first quarter ended March 31, 2013.
Sign-up for Regency Energy Partners Announces Cash Distribution of 46 Cents Per Outstanding Common Unit investment picks
2013/4/30
Regency Energy Partners LP ( NYSE: RGP ) announced today that it has closed on the previously announced acquisition of Southern Union Gathering Company, LLC, the owner of Southern Union Gas Services, Ltd.
Sign-up for Regency Energy Partners Closes on Acquisition of Southern Union Gathering Company, LLC investment picks
2013/3/1
Regency Energy Partners LP ( NYSE: RGP ), (“Regency” or the “Partnership”), filed its annual report on Form 10-K for the fiscal year ended December 31, 2012, with the Securities and Exchange Commission on March 1, 2013.
Sign-up for Regency Energy Partners Files 2012 Annual Report investment picks
2013/4/24
Regency Energy Partners LP (NYSE: RGP) (“Regency”) today announced that it has priced a private offering of $600 million in aggregate principal amount of 4.500% Senior Notes due 2023.
Sign-up for Regency Energy Partners LP Announces Pricing of Private Offering of Senior Notes investment picks
2013/4/24
Regency Energy Partners LP (NYSE: RGP) (“Regency”) today announced a private offering of $600 million of its senior notes due 2023.
Sign-up for Regency Energy Partners LP Announces Private Offering of Senior Notes investment picks
2013/5/8
Regency Energy Partners LP ( NYSE: RGP ), (“Regency” or the “Partnership”), announced today its financial results for the first-quarter ended March 31, 2013.
Sign-up for Regency Energy Partners Reports First-Quarter 2013 Results investment picks
2013/2/27
Regency Energy Partners LP ( NYSE: RGP ) today announced it will acquire Southern Union Gathering Company, LLC, the owner of Southern Union Gas Services, Ltd.
Sign-up for Regency Energy Partners to Acquire Southern Union Gathering Company, LLC for $1.5 Billion investment picks
2013/6/4
Regency Energy Partners LP (NYSE: RGP) will host its sixth-annual meeting for analysts and investors, Tuesday, June 11 th at the Rosewood Crescent Hotel in Dallas.
Sign-up for Regency Energy Partners to Host Annual Investor Day investment picks
2013/5/3
TARRYTOWN, N.Y. , May 3, 2013 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it has expanded its ophthalmology portfolio by acquiring full exclusive rights to two families of novel antibodies invented at Regeneron and previously included in Regeneron's antibody collaboration with Sanofi.
Sign-up for Regeneron Acquires Full Rights to Two Novel Ophthalmology Development Programs investment picks
2013/2/19
TARRYTOWN, N.Y. and BERLIN , Feb.
Sign-up for Regeneron and Bayer Initiate Phase 3 Trial of EYLEA® (aflibercept) Injection for the Treatment of Diabetic Macular Edema in Asia and Russia investment picks
2013/6/6
TARRYTOWN, N.Y. , June 06, 2013 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Bayer HealthCare today announced positive top-line results for EYLEA ® (aflibercept) Injection from the Phase 3 MYRROR study in myopic choroidal neovascularization (mCNV).  In this trial, patients receiving EYLEA at an initial dose of 2 milligrams (mg), followed by treatment on an as-needed (PRN) basis, had a mean improvement in best-corrected visual acuity (BCVA) from baseline at week 24 of 12.1 letters, compared to a loss of 2.0 letters in patients receiving sham injections (p<0.0001).  The most common adverse events observed in the MYRROR trial that occurred with a frequency of 2% or more were conjunctival hemorrhage, dry eye, eye pain, headache and nasopharyngitis.
Sign-up for Regeneron and Bayer Report Positive Phase 3 Results for EYLEA® (aflibercept) Injection in Myopic Choroidal Neovascularization (mCNV) investment picks
2013/3/4
Regeneron receives 4% to 15% royalty on sales of Ilaris TARRYTOWN, N.Y. , March 4, 2013 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will receive an additional potential royalty stream now that the European Commission (EC) has approved Novartis' llaris (canakinumab, ACZ885) in the treatment of patients with acute gouty arthritis who suffer frequent attacks, and whose symptoms cannot or should not be managed with current treatment options.
Sign-up for Regeneron Announces Potential Additional Royalty Stream Related to EU Approval for Ilaris® (canakinumab) in Patients Suffering Acute Gouty Arthritis Attacks Who Cannot Gain Relief From Current Treatments investment picks
2013/2/11
TARRYTOWN, N.Y. , Feb.
Sign-up for Regeneron Announces Receipt of Hart-Scott-Rodino Notice investment picks
2013/2/19
TARRYTOWN, N.Y., Feb.
Sign-up for Regeneron Announces Upcoming 2013 Investor Conference Presentations investment picks
2013/4/18
TARRYTOWN, N.Y. , April 18, 2013 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management presentations at the following investor conferences: Baird's 2013 Growth Stock Conference on Wednesday, May 8 , 2013.
Sign-up for Regeneron Announces Upcoming 2013 Investor Conference Presentations investment picks
2013/5/8
TARRYTOWN, N.Y. , May 8, 2013 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) will webcast management presentations at the following investor conferences: UBS Global Healthcare Conference on Monday, May 20 , 2013.
Sign-up for Regeneron Announces Upcoming 2013 Investor Conference Presentations investment picks
2013/4/4
TARRYTOWN, N.Y. , April 4, 2013 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the Company will expand the Regeneron corporate headquarters and laboratories in Westchester County and create more than 400 new high-skill jobs.
Sign-up for Regeneron Pharmaceuticals Announces Expansion in New York's Hudson Valley investment picks
2013/4/29
Regeneron Pharmaceuticals Inc.'s (REGN) stock price tripled last year, and the compensation of co-founder and Chief Executive Leonard Schleifer nearly did, too.
Sign-up for Regeneron Pharmaceuticals Co-Founder Receives $81.55 Million Compensation investment picks
2013/5/3
- First quarter EYLEA® (aflibercept) Injection net sales of $314 million in the U.S. and $65 million in rest of world - Estimated full year 2013 EYLEA U.S. net sales forecast raised to $1.25 billion - $1.325 billion - First quarter non-GAAP net income of $201 million or $1.78 per diluted share TARRYTOWN, N.Y. , May 3, 2013 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced financial and operating results for the first quarter of 2013 and provided an update on development programs.
Sign-up for Regeneron Reports First Quarter 2013 Financial and Operating Results investment picks
2013/4/24
NEW YORK , April 24, 2013 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400 and the S&P SmallCap 600 indices: S&P MidCap 400 constituent Regeneron Pharmaceuticals Inc. (NASD:REGN) will replace MetroPCS Communications Inc. (NYSE:PCS) in the S&P 500, S&P SmallCap 600 constituent Eagle Materials Inc. (NYSE:EXP) will replace Regeneron in the S&P MidCap 400, and Francesca's Holdings Corp.
Sign-up for Regeneron Set to Join the S&P 500; Eagle Materials, CST Brands to Join the S&P MidCap 400; Francesca's, Northern Oil & Gas to Join the S&P SmallCap 600 investment picks
2013/4/11
TARRYTOWN, N.Y. , April 11, 2013 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its first quarter 2013 financial and operating results on Friday, May 3, 2013 , before the U.S. financial markets open.
Sign-up for Regeneron to Report First Quarter 2013 Financial and Operating Results and Host Conference Call and Webcast on May 3, 2013 investment picks
2013/5/21
An experimental drug being developed by Regeneron Pharmaceuticals Inc. (REGN) and Sanofi SA (SNY) showed promising results during a small, mid-stage clinical trial in treating a subset of patients with moderate to severe asthma, but some physicians cautioned that it was too early to say how effective the treatment may ultimately be.
Sign-up for Regeneron-Sanofi Asthma Drug Shows Promising Early Results investment picks
2013/6/6
Regeneron Pharmaceuticals Inc. (REGN) and a Bayer AG (BAYRY, BAYN.XE) unit said a late-stage study showed Eylea improved best-corrected visual acuity in patients with myopic choroidal neovascularization.
Sign-up for Regeneron: Study Shows Eylea Improves Vision Acuity in Retina Disease investment picks
2013/4/16
U.S. Bancorp (USB) and Comerica Inc. (CMA), two of the nation's most financially stable regional banks, resorted to expense cuts in the first quarter to offset slowing revenue from mortgage and business lending.
Sign-up for Regional Banks Cut Costs in the 1st Quarter to Increase Earnings investment picks
2013/3/1
http://media.marketwire.com/attachments/201106/79917_Shinesroomlogo15.06.11.JPG http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=991902&ProfileId=051205&sourceType=1 NEW YORK, NY --
Sign-up for Regional Banks to Benefit From Loan Growth and Improving Credit Quality investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Regency Centers Reports First Quarter Results to Regional Banks to Benefit From Loan Growth and Improving Credit Quality
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity